Minimize Uncertainty – Make Informed Decisions – Succeed

Health Mobile Apps Landscape in H2 2025

February 12, 2026psoriasis,DEMENTIA,Our Insights,Parkinson's Disease,hemophilia,diabetes,digital health,Ulcerative Colitis,Respiratory,Crohns Disease,Oncology,Arthritis,migraine,Kidney Health,mhealth,Healthcare Technology,multiple sclerosis,inflammatory bowel disease,health apps,Major depressive disorder,mobile health,digital health maturity,digital therapeutics,patient monitoring,nephrology,Health Mobile Apps ReportsAlzheimer's Disease,cardiovascular

Trending in Health Mobile Apps: Current Trends, Rankings and Insights from H2…

by LucidQuest

Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: ILiAD Biotechnologies $115 million Series B for pertussis vax

February 12, 2026Vaccines,clinical trials,market access,Regulatory,biopharma,Lucid Diligence Brief,payer access,diligence,pertussis,CHIM,mucosal immunology,UKHSAACIP

Lucid Diligence Brief: ILiAD Biotechnologies $115 million Series B for…

by Timos Papagatsias

Immunology

Immunology Video Recap—February 11, 2026

February 11, 2026Systemic lupus erythematosus,Chronic graft-versus-host disease,astrazeneca,Anifrolumab,sanofi,Saphnelo,BioPharma and Tech News,Cutaneous lupus erythematosus,Galderma,litifilimab,gastric cancer,warm autoimmune hemolytic anemia,Ulcerative Colitis,cutaneous sarcoidosis,Imfinzi,TULIP-SC Trial,Biogen,Durvalumab,Rilzabrutinib,MATTERHORN Trial,Immunology News,Rezurock,Everest Medicines,Belumosudil,etrasimod,RelabotulinumtoxinA,VELSIPITY,Priovant TherapeuticsWayrilz,Brepocitinib

This biweekly Immunology video recap summarizes key regulatory actions,…

by LucidQuest

Immunology

Immunology Today—February 11, 2026

February 11, 2026abbvie,sanofi,BioPharma and Tech News,Eli Lilly,Ulcerative Colitis,Rilzabrutinib,Immunology News,etrasimod,warm autoimmune hemolytic anemiacutaneous sarcoidosis,vedolizumab biosimilar

This weekly Immunology update covers regulatory actions, clinical progress,…

by LucidQuest

Neuroscience

Neuroscience Today—February 11, 2026

February 11, 2026migraine,Alzheimer's Disease,Spinal Muscular Atrophy,BioPharma and Tech News,Biogen,Neuroscience News,Fenebrutinib,narcolepsy type 1,Primary progressive multiple sclerosisOcrevus,Orexin agonist

This weekly Neuroscience update summarizes regulatory milestones, late-stage…

by LucidQuest

Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Nektar's REZPEG in atopic dermatitis

February 11, 2026clinical trials,market access,Regulatory,immunology,dermatology,biopharma,Lucid Diligence Brief,payer accessdiligence

Lucid Diligence Brief: Nektar's REZPEG in atopic dermatitis Professional…

by Timos Papagatsias

Endocrinology

Endocrinology Video Recap—February 10, 2026

February 10, 2026Tandem Diabetes Care,Arecor,FDA,BioPharma and Tech News,type 1 diabetes,China,Endocrinology News,Sciwind Biosciences,Diabetic peripheral neuropathic pain,Pilavapadin,Closed-loop insulin delivery,Xianyida,Glucagon-Like Peptide-1,Lexicon PharmaceuticalsAutonomic Diabetic Peripheral Sensory Neuropathy,Helmsley Charitable Trust

Biweekly Endocrinology video recap covering regulatory actions, clinical…

by LucidQuest

Endocrinology

Endocrinology Today—February 10, 2026

February 10, 2026BioPharma and Tech News,Tirzepatideosteoporosis,type 2 diabetes,GLP-1 receptor agonist,Endocrinology News,Continuous Glucose Monitoring,bone mineral density,Functional hypothalamic amenorrhea,Transdermal hormone replacement therapy,Artificial intelligence in endocrinology

This weekly update in endocrinology covers regulatory approvals and launches,…

by LucidQuest

Obesity Weekly News

Obesity Today—February 10, 2026

February 10, 2026wegovy,semaglutide,pfizer,BioPharma and Tech News,Novo Nordisk,Eli Lilly,type 2 diabetes,GLP-1 receptor agonist,Obesity NewsCagriSema,FDA regulation

This is a weekly update in Obesity, covering key regulatory actions, late-stage…

by LucidQuest

Lucid Diligence Brief - Tech

Lucid Diligence Brief: Iambic Takeda AI drug discovery collaboration

February 10, 2026Oncology,drug discovery,AI in healthcare,biopharma,Lucid Diligence Brief,payer access,diligence,R&D strategy,milestones,gastrointestinalstrategic partnerships

Lucid Diligence Brief: Iambic Takeda AI drug discovery collaboration…

by Timos Papagatsias

Artificial_Intelligence

AI in Healthcare and Digital Health Video Recap—February 9, 2026

February 9, 2026Lotus Health AI,CardioMEMS Heart Failure System,Siri,Galaxy Ring,BioPharma and Tech News,Health App,OpenAI,American Association of Heart Failure Nurses,AI in Healthcare and Digital Health,Abbott,Apple,Heart Failure Society of America,Prism,GPT-5.2,OpenClaw,Samsung Health,Galaxy Watch 8Dobot,UBTech

This biweekly AI in Healthcare and Digital Health video recap covers major…

by Timos Papagatsias

Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Innovent - Eli Lilly Global R&D Alliance

February 9, 2026Oncology,clinical trials,Regulatory,immunology,biopharma,Lucid Diligence Brief,payer access,diligence,partnerships,China biotechcross-border R&D

Lucid Diligence Brief: Innovent - Eli Lilly Global R&D Alliance…

by Timos Papagatsias

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required
You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.